🔴 Neuroone Medical Technologies is trading 5% down with no confirmed company-specific catalyst

Neuroone Medical Technologies is trading 5.28% down at $0.99; no confirmed company-specific catalyst was identified for the October 16 decline.

• The Nasdaq fell 1.37% and the S&P 500 declined 0.59% in the supplied market context; risk-off trading may be contributing but does not establish a direct cause.
• Recent revenue and NIH-grant announcements predate the move.